Comment: Raised Soluble P Selectin and the Risk of Thrombosis in HIV-1 Infection

Thromb Haemost 2002; 88(06): 1078
DOI: 10.1055/s-0037-1613365

Letters to the Editor

Schattauer GmbH

A. Blann

¹The City Hospital, University Department of Medicine, Birmingham. UK

References
1 Karpatkin S, Nardi M, Green D. Platelet and coagulation defects associated with HIV-1 infection. Thromb Haemost 2002; 88: 389-401.
2 Blann AD, Lip GYH. Hypothesis: Is soluble P-selectin a new marker of platelet activation?. Atherosclerosis 1997; 128: 135-8.
3 Capron L, Kim YU, Laurin C, Bruneval P, Fiessinger DIN. Atheroembolism in HIV-positive individuals. Lancet 1992; 340: 1039-40.
4 Blann AD, Seigneur M, Constans J, Pellegrin JL, Conri C. Soluble P selectin, thrombocytopenia and von Willebrand factor in HIV infected patients. Thromb Haemost 1997; 77: 1221-2.
5 Wagner DD. Cell biology of von Willebrand factor. Annu Rev Cell Biol 1990; 06: 217-46.
6 Guerin V, Morlat P, Chene G, Grobost F, Aubertin J, Boisseau M. High levels of plasmatic von Willebrand factor limits the bleeding time in thrombocytopaenic HIV-infected patients. Thromb Haemost 1995; 74: 646-9.